BDX — BCAL Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$21.96m
- AU$19.81m
- AU$2.65m
Annual cashflow statement for BCAL Diagnostics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | 0.4 | 0.295 | 1.04 | 3.09 | 2.82 |
| Change in Other Assets | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.21 | -3.22 | -6.05 | -4.52 | -6.14 |
| Capital Expenditures | -0.004 | -0.026 | -0.362 | -1.15 | -0.788 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | -4 | 4 | — | — |
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.004 | -4.03 | 3.64 | -1.15 | -0.788 |
| Financing Cash Flow Items | -0.208 | -0.622 | 0 | -0.165 | -0.115 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.2 | 9.41 | 0.013 | 8.97 | 4.97 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.99 | 2.16 | -2.4 | 3.3 | -1.95 |